+128.1% · 90d
$86.74
-4.94 (-5.39%)
After-Hours $87.10(+0.36)
News
(1)April 2026
Nektar's rezpegaldesleukin shows clear hair regrowth benefits for severe alopecia areata
NKTRNEKTAR THERAPEUTICS
# 📊 What This Document Is 📰 This filing is an 8-K, which is a required SEC report used by companies to announce major, unscheduled corporate events. Think of it as an urgent "heads up" bulletin to investors. In this case, Nektar Therapeutics is announcing the impressive results from an extended st
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%